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Background: Left hemicolectomy, sigmoid, and rectal resections are commonly 
performed colorectal operations. There is significant vVariability exists in the 
techniques utilised to undertake these operations, as well as at patient, surgeon and 
unit level. 
 
Aim: To explore differences in patients, techniques and outcomes across anthe 
international cohort to identify areas of practice variability resulting in apparent 
differences in outcome warranting further study. 
 
Endpoints: A three-stage data collection strategy collecting patient demographics, 
operative details and outcome markers. Several outcomes measures will be used 
including mortality, surgical morbidity (including anastomotic leak) and length of 
hospital stay. 
 
Methods: A two-month prospective audit to be performed across Europe in early 
2017, co-ordinated by the European Society of Coloproctology. The main audit will 
be preceded by a one-week, five centre pilot. Sites will be asked to pre-register for 
the audit and obtain appropriate regional or national approvals. During the study 
period all eligible operations will be recorded contemporaneously and followed-up 
through to 30 days. The audit will be performed using a standardised pre-determined 
protocol and a secure online database. In the first ESCP conducted audit in 2015, 38 
countries registered 3208 patients undergoing right hemi-colectomy, while in the 
second audit 2441 patients undergoing stoma closure were recruited from 48 
countries. It is expected that equivalent numbers will be obtained in this audit. The 
report of this audit will be prepared in accordance with guidelines set by the 
STROBE (strengthening the reporting of observational studies in epidemiology) 
statement for observational studies. 
 
Discussion: This multicentre, pan-European audit will be delivered by colorectal 




about areas of variability in provision or practice, and how this may impact upon 
outcomes, will serve to improve overall patient care as well as being hypothesis 




































































































































































































































































































Registered  local  investigators will have  individual password‐protected access to their unit’s 
data entered on to REDCap. During the running of the audit, only local data will be visible to 
investigators; other sites’ data will not be accessible.  
In order  to  facilitate entry of  follow‐up data,  investigators will need a way  to  link REDCap 
records  to  patient  records.  This  can  be  achieved  by  keeping  a  password  protected 



























































































































Date of surgery _____ / _____ / _____  This is an optional field to help you identify and follow up patients 
Gender  Male  Female   
Age _____   Age on day of operation 
ASA grade  Grade I: healthy person  Grade II: mild systemic 
disease 
 Grade III: severe 
systemic disease 
. 
  Grade IV: systemic disease that is a constant threat to life  Grade V: moribund  
History of IHD/ stroke  Yes  No  IHD = ischaemic heart disease 
History of anticoagulant treatment  Yes  No  Anti-coagulant use (e.g. warfarin, coumadin) 
prior to admission to hospital 
History of diabetes mellitus  Yes  No  Include diet, tablet and insulin controlled DM 
Smoking history  Never  Ex-smoker: stopped 
more than 6 weeks ago 
 Ex-smoker: stopped 
less than 6 weeks ago 
 
  Current smoker  
Body Mass Index _____                 If BMI unknown: Weight: _____ kg Height: _____ cm Height/weight only required if BMI unavailable 
Preoperative nutritional support  None  Oral supplement  Parenteral nutrition  
  Enteral  nutrition (NG tube, PEG)   
Urgency of surgery  Elective (planned)  Expedited  Emergency Expedited: within 2 weeks of decision 
Emergency: within 24 hours of decision 
Indication  Benign polyp  Crohn's disease  Diverticular disease  
  Malignancy (cancer)  Trauma  Ulcerative colitis  
  Other: ____________________________________________  
Location of disease  Splenic flexure  Left colon  Sigmoid colon For synchronous tumours you may select 
multiple sites   High rectum (11-15cm)  Middle rectum (7-10cm)  Low rectum (0-6cm) 
Pre-operative albumin _____ g/L or mmol/L                  Enter most recent pre-operative value 
Pre-operative haemoglobin _____ g/L or mmol/L                  Enter most recent pre-operative value 
Pre-operative enteric fistula  Yes  No  Fistula between bowel and other organ/ skin 
Pre-operative abscess  Yes  No  Intra-abdominal or pelvic abscess, within 3 
months of surgery 
If yes: US or CT guided percutaneous 
abscess drainage  
 Yes  No Include US/ CT drainage procedures 
completed within 3 months of surgery 





Crohn’s disease extension data points    
Pre-operative immunosuppressant 
drugs 
select multiple drugs, if appropriate 
 Steroids, low dose  Steroids, high dose (≥20mg prednisolone or equivalent) Low dose: <20mg prednisolone or equivalent 
 6-mercaptopurine  Methotrexate  Azathioprine Include systemic steroids given within a 
week of surgery. Include 6MP, MTX, 
azathioprine given within a month of surgery. 
Pre-operative biologic use  None  1w prior to surgery  1-6w prior to surgery w = weeks 
  6-12w prior to surgery  12w to 1 year prior to surgery  select multiple options, if appropriate 
Steroid stress dose  Yes  No  A single high dose of steroids at induction to 
reduce surgical stress response in patients 
already on steroids 
Cancer extension data points   
Initial pre-treatment staging (no neoadjuvant therapy given, or prior to neoadjuvant therapy if it was given):  
T stage  T1  T2  T3  
  T4    
N stage  N0  N1  N2  
M stage  M0  M1   
EMVI detected on MRI  Yes  No   
Threatened (<2mm) CRM on MRI  Yes  No   
Neoadjuvant therapy:     
What neoadjuvant (pre-operative) 
therapy was administered, if any 
 None  Chemotherapy only  SCRT: short-course radiotherapy 
 Long-course chemoradiotherapy   
Post-treatment staging (for patients who underwent neoadjuvant therapy, repeat staging prior to surgery): 
Was the patient re-staged following 
neoadjuvant treatment 
 Yes 
(complete details below) 
 No  Not applicable (no neoadjuvant treatment) 
T stage  T1  T2  T3  
  T4    
N stage  N0  N1  N2  
M stage  M0  M1   
EMVI detected on MRI  Yes  No  EMVI = extramural venous invasion -  
Threatened (<2mm) CRM on MRI  Yes  No  CRM = circumferential resection margin 





Pre-operative bowel preparation  None  MBP only  MBP + preop oral 
antibiotics 
MBP = Mechanical bowel preparation 
Surgeon in charge  Colorectal trainee  Colorectal consultant surgeon Consultant = attending/ specialist 
Trainee = registrar/ resident   General surgery trainee  General consultant surgeon 
Proximal level of bowel transection Select C1 – C9: _____   Please refer to diagram on page 7 
Distal level of bowel transection Select C4 – Cx: _____   Please refer to diagram on page 7 
Intra-operative findings  Enteric fistula  Acute colitis/ proctitis  Bowel perforation You may select multiple findings 
  Bowel obstruction  Intra-abdominal / pelvic abscess  
Initial operative approach  Open  Robotic  Laparoscopic Conversion to open: wound made or 
extended to allow access to vascular pedicle 
or to complete safe dissection 
If robotic/ laparoscopic: Was this converted to open  Yes  No 
Was a part of the operation 
undertaken with a transanal 
approach? 
 Yes  No   
Operation duration (mins) _____ minutes   Time from incision to skin closure 
Skin closure  Suturing  Stapling   
Intra-operative blood transfusion  Yes  No   
Intra-operative complications  None  Vascular injury  Bowel injury (e.g. 
duodenum) 
 
  Injury to adjacent organs or structures (e.g. ureter)  
Anatomosis  Handsewn  Staples  None  
  If no anastomosis:  Standard APR  Inter-sphincteric APR  Extra-levator APR  
  Hartmann type-operation (rectal stump left)  
If handsewn or stapled anastomosis  
Anastomotic configuration  Side to side  Side to end  End to end  
Anastomosis distance from anus _____ cm   Only required for rectal resections 
Intra-operative leak test performed?  Yes  No   
De-functioning stoma  Loop ileostomy  End ileostomy  Loop colostomy  







Handsewn anastomosis extension data points    
Technique for primary anastomosis  Continuous sutured  Interrupted sutured   
Suture material for primary 
anastomosis 
 Biosyn   Capron (Nurolon)  Catgut  
 Dexon  Ethibond (TiCron)  Maxon  
  Monocryl  Monomax  Monosyn  
  Nylon (Ethilon)  PDS (Monoplus)  Polysorb  
  Prolene (SurgiPro)  Safil  Silk  
  Vicryl (Novosyn)  Other: _____________   
Suture gauge for primary 
anastomosis 
_____    e.g. 6-0, 5-0, 4-0, 3-0, 2-0, 1-0, 0, 1, 2 etc 
Bites taken for primary anastomosis  Full thickness bowel  Sero-muscular only   
Number of layers  Single layer  Two layers  Two layers = another layer of sutures taken 
after the primary bowel anastomosis is 
completed 
Stapled anastomosis extension data points  
Device for primary anastomosis  Linear  Circular   
If circular stapler used     
Device for primary anastomosis  CDH (Ethicon)  CEEA  (Covidien)  ECS (Ethicon)  
  EEA  (Covidien)  SDH (Ethicon)  Other: _____________  
Stapler diameter size _____ mm   Circular stapler diameters vary 21-33mm 
If linear stapler used     
Device for primary anastomosis  Endopath (Ethicon)  GIA (Covidien)  NTLC (Ethicon)  
  TA (Covidien)  TCT (Ethicon)  TL (Covidien)  
  TLC (Ethicon)  TX (Ethicon)  Other: _____________  
Was apex of anastomosis stapled?  Yes  No   
If apex stapled, device used:  Endopath (Ethicon)  GIA (Covidien)  NTLC (Ethicon)  
  TA (Covidien)  TCT (Ethicon)  TL (Covidien)  
  TLC (Ethicon)  TX (Ethicon)  Other: _____________  





Post-operative admission to 
intensive care unit 
 No admission to ICU  Planned from operating theatre Intensive care unit = ICU/ ITU/ Critical care 
unit  Unplanned, from ward  Unplanned, from operating theatre 
Peak CRP level _____ mg/L Peak CRP level up to and including on post-operative day three (day of operation is day zero) 
Clavien-Dindo complication grade  None  Grade I  Grade II  Grade IIIa 
  Grade IIIb  Grade IVa  Grade IVb  Grade V 
Anastomotic leak  None  Yes – Grade A  Yes – Grade B Grade A = no radiological or surgical 
intervention 
Grade B = radiological intervention (eg drain) 
  Yes – Grade C: surgical intervention  
If anastomotic leak occured: Post operative day anastomotic leak diagnosed: _____ 
Intra-abdominal or pelvic collection  Yes  No   
If collection occured: Post operative day anastomotic leak diagnosed: _____ The day of operation is day zero. 
Surgical site infection  Yes  No   
Length of post op stay _____ days    
30 day readmission  Yes  No   
If readmitted, reason for readmission: _____________________________________________________________________________  
30 day reoperation  Yes  No   
  If reoperated, reason for reoperation:  Anastomotic leak  Bowel obstruction  Hernia  
  Wound related problem  Other: __________________________________________  
Postop histology  Benign polyp  Crohn’s disease  Diverticular disease  
  Malignancy (cancer)  Ulcerative colitis  Other: _____________  
Cancer extension data points:    
Grade of differentiation  Well differentiated  Moderate differentiation  Poorly differentiated  
Histological T stage (post-op)  T0  T1  T2  
  T3  T4   
Histological N stage (post-op)  N0  N1  N2  
Histological M stage (post-op)  M0  M1   
Complete pathological response  Yes  No   
Number of harvested lymph nodes _____   
Number of lymph nodes with metastases _____   
Histological evidence of EMVI  Yes  No  EMVI = extramural venous invasion 
Distance to closest resection margin _____ mm    
TABLE 1 – Audit timelines 
	
Key dates: 
22 December 2016 Draft protocol published
1 February 2017 
to 15 March 2017 
Patient inclusion window starts
Sites should start collecting at least 8 weeks of consecutive 
patient operations within this window. 
Sites should follow up each patient for 30 days. 
10 May 2017  Last day of operation to include in data collection 
9 June 2017  Last day of patient follow up (8 weeks from patients 
operated on 10 May 2017). 
30 June 2017  REDCap database locked
This is the deadline for data submission 
22 September 2017 Preliminary data at ESCP 2017 Berlin
	
 
TABLE 2‐ Unit questionnaire  
To	be	completed	at	site	registration	stage	
 
Provision of surgical services   
Is your centre a:  University hospital/ tertiary centre;  
District general hospital;  
How many consultant‐level surgeons 
perform colorectal resection operations 
at your site? 
(number) 
How many consultant‐level specialist 
colorectal surgeons are at your site 
(number) 
How many beds are in your hospital in 
total (all specialties)? 
(number) 
How many general surgical beds are in 
your hospital? 
(number) 
How many high dependency (HDU) and 
intensive care (ITU) beds are in your 
hospital?  
(number) 
 
